20 Apr 2017 published April 2017
The British Pharmacological Society is proud to have four Advisory Groups to represent the interests and views of its diverse membership. The Advisory Groups make a valued contribution to the Society’s activities by ensuring that members' needs are listened to and addressed. The success of these groups has paved way for the formation of a new group in 2017: the International Advisory Group.
Ahead of Women’s History Month in March, we organised a Women in Pharmacology event to celebrate the achievements of female pharmacologists at King’s College London (KCL). This event was a collaboration between British Pharmacological Society, KCL Bioscience Students’ Association and KCL Pharmacological Society.
18 Apr 2017 published April 2017
Clinical trials are at the heart of modern medical research. They are the best means we have of testing whether a medicine is safe and whether it works. Around the world, pharmaceutical companies, universities, government research institutes and medical charities run tens of thousands of trials every year. So it’s a problem that the results of around half of all clinical trials currently remain hidden.
During the last Olympics, the Team GB medal haul was their best since 1908. Many commentators attributed this to the ‘aggregation of marginal gains’. We can apply this concept to refining techniques in animal research. In this article, we focus on the ‘R’ of refinement and present examples of how small changes to everyday procedures can be implemented to refine experimental procedures.
23 Nov 2016 in Editorial published November 2016
It has certainly been a very busy year, and I personally cannot believe that we are close to the festive holidays already… Where has this year gone?
23 Nov 2016 in Your Society published November 2016
It’s hard to believe that when this is published, we will be approximately a month away from Pharmacology 2016. The team at the Schild Plot is focused on delivering another lively and successful meeting, with many new activities planned.
23 Nov 2016 published November 2016
In vivo knowledge and skills have always been essential in academic research labs that investigate basic physiology, ageing, diseases and their pharmacological treatments. Their importance has increased as researchers have sought to understand the functional significance of genomic information, particularly through the use of transgenic models.
Novel Psychoactive Substances, also referred to as ‘legal highs’, represent a bewildering array of unregulated psychoactive compounds, marketed globally as legal alternatives to well-known controlled drugs.
The British Pharmacological Society is proud to be a global community at the heart of pharmacology: our journals have a global readership, a fifth of our membership is international, and we represent scientists from more than 60 countries worldwide.
The Institute, based near Barbican in Central London, was founded in in 1986 by Nobel Laureate Sir John Vane, whose ground-breaking work on the mechanism of action of aspirin fathered research into the roles lipids play during inflammation
Olga was one of the four young researchers to receive funding from the British Pharmacological Society’s Young Pharmacologists Advisory Group to attend the Italian Pharmacological Society’s conference.
Our magazine publishes articles on current issues and perspectives in pharmacology.
Browse the library